What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

PUBLISHER: 360iResearch | PRODUCT CODE: 1317916

PUBLISHER: 360iResearch | PRODUCT CODE: 1317916

Muscle Relaxants Drug Market by Drug, Distribution - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

PUBLISHED: June 12, 2023

PAGES: 181 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The Global Muscle Relaxants Drug Market is forecasted to grow significantly, with a projected USD 4,442.30 million in 2023 at a CAGR of 7.86% and expected to reach a staggering USD 7,555.09 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Muscle Relaxants Drug Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Muscle Relaxants Drug Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drug, market is studied across Facial Muscle Relaxant, Neuromuscular Relaxant, and Skeletal Muscle Relaxant. The Skeletal Muscle Relaxant is projected to witness significant market share during forecast period.

Based on Distribution, market is studied across Clinics, Drug Stores, Hospitals, and Online Stores. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Muscle Relaxants Drug Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Muscle Relaxants Drug Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Muscle Relaxants Drug Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Muscle Relaxants Drug Market?

4. What is the competitive strategic window for opportunities in the Global Muscle Relaxants Drug Market?

5. What are the technology trends and regulatory frameworks in the Global Muscle Relaxants Drug Market?

6. What is the market share of the leading vendors in the Global Muscle Relaxants Drug Market?

7. What modes and strategic moves are considered suitable for entering the Global Muscle Relaxants Drug Market?

Product Code: MRR-036C5CF3A8AF

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Muscle Relaxants Drug Market, by Drug, 2022 vs 2030
4.3. Muscle Relaxants Drug Market, by Distribution, 2022 vs 2030
4.4. Muscle Relaxants Drug Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing prevalence of lower back pain and other musculoskeletal disorders
  - 5.1.1.2. Surge in surgeries in geriatric population
  - 5.1.1.3. Increasing healthcare expenditure
- 5.1.2. Restraints
  - 5.1.2.1. Side effects associated with muscle relaxant drugs such as habituation and respiratory arrest
- 5.1.3. Opportunities
  - 5.1.3.1. Growing R&D activities for the development of novel drugs with FDA approvals and strategic collaborations
  - 5.1.3.2. Potential growth in emerging economies
- 5.1.4. Challenges
  - 5.1.4.1. Counterfeit drugs in developing countries
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Muscle Relaxants Drug Market, by Drug

6.1. Introduction
6.2. Facial Muscle Relaxant
6.3. Neuromuscular Relaxant
6.4. Skeletal Muscle Relaxant

7. Muscle Relaxants Drug Market, by Distribution

7.1. Introduction
7.2. Clinics
7.3. Drug Stores
7.4. Hospitals
7.5. Online Stores

8. Americas Muscle Relaxants Drug Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Muscle Relaxants Drug Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Muscle Relaxants Drug Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing

Product Code: MRR-036C5CF3A8AF

LIST OF FIGURES

FIGURE 1. MUSCLE RELAXANTS DRUG MARKET RESEARCH PROCESS
FIGURE 2. MUSCLE RELAXANTS DRUG MARKET SIZE, 2022 VS 2030
FIGURE 3. MUSCLE RELAXANTS DRUG MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2022 VS 2030 (%)
FIGURE 5. MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2022 VS 2030 (%)
FIGURE 6. MUSCLE RELAXANTS DRUG MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 7. MUSCLE RELAXANTS DRUG MARKET DYNAMICS
FIGURE 8. MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. MUSCLE RELAXANTS DRUG MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 15. MUSCLE RELAXANTS DRUG MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. MUSCLE RELAXANTS DRUG MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. MUSCLE RELAXANTS DRUG MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 5. MUSCLE RELAXANTS DRUG MARKET SIZE, BY FACIAL MUSCLE RELAXANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. MUSCLE RELAXANTS DRUG MARKET SIZE, BY NEUROMUSCULAR RELAXANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MUSCLE RELAXANTS DRUG MARKET SIZE, BY SKELETAL MUSCLE RELAXANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 9. MUSCLE RELAXANTS DRUG MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. MUSCLE RELAXANTS DRUG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. MUSCLE RELAXANTS DRUG MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 20. CANADA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 21. CANADA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 22. MEXICO MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 23. MEXICO MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 30. AUSTRALIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 32. CHINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 33. CHINA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 34. INDIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 35. INDIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 36. INDONESIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 38. JAPAN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 39. JAPAN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 40. MALAYSIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 42. PHILIPPINES MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 44. SINGAPORE MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 46. SOUTH KOREA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 48. TAIWAN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 50. THAILAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 51. THAILAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 52. VIETNAM MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 57. DENMARK MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 58. DENMARK MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 59. EGYPT MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 60. EGYPT MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 61. FINLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 62. FINLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 63. FRANCE MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 64. FRANCE MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 65. GERMANY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 66. GERMANY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 69. ITALY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 70. ITALY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 71. NETHERLANDS MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 73. NIGERIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 75. NORWAY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 76. NORWAY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 77. POLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 78. POLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 79. QATAR MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 80. QATAR MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 87. SPAIN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 88. SPAIN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 89. SWEDEN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 91. SWITZERLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 93. TURKEY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 94. TURKEY MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM MUSCLE RELAXANTS DRUG MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM MUSCLE RELAXANTS DRUG MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 99. MUSCLE RELAXANTS DRUG MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 100. MUSCLE RELAXANTS DRUG MARKET SHARE, BY KEY PLAYER, 2022
TABLE 101. MUSCLE RELAXANTS DRUG MARKET LICENSE & PRICING